Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

5.48%

34.5¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-285

First 285 Last

Share
Profile

Follow
Mikey74

1,383 Posts.

283

20/06/24

23:20

Post #: 74415784
Share

Originally posted by dachopper: ↑

Understood, you are quoting a hypothetical net sales figure that was used by BOT as a hypothetical. They never said it would be that, and it's not net profit so you can't use it to calculate PE. My point was it cannot possibly be net profit as Tax alone is bigger than the margin.

BOT did say the price would command a higher value than competitors which are $690 a month. So we have a definante gross sales at least starting in the 700's.

When calculating PE, it's based on overall company profit and that needs to take into account all costs ( not just sales cost)

Having said that now, we are miles away from sales so SP could do anything in the meantime. It will respond to market demand, that should be good while we await Q4.

Expand

While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41

In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of these
negotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at a
level commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.

Last edited by Mikey74: 20/06/24

BOT Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

RCE

Recce's R327 found effective against E.coli during clinical trial

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

There are more pages in this discussion • 209 more messages in this thread...

First 285 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 34.5¢		Change -0.020(5.48%)		Mkt cap ! $551.2M

Open	High	Low	Value	Volume
35.5¢	35.5¢	34.0¢	$3.341M	9.607M

Buyers (Bids)

No.	Vol.	Price($)
13	806408	34.5¢

Sellers (Offers)

Price($)	Vol.	No.
35.0¢	316293	11

View Market Depth

No.	Vol.	Price($)
10	645575	0.345
26	1323358	0.340
15	1052630	0.335
30	2609317	0.330
9	1704368	0.325

Price($)	Vol.	No.
0.350	415373	11
0.355	75085	3
0.360	173992	5
0.365	290551	4
0.370	257356	8

Last trade - 13.34pm 28/06/2024 (20 minute delay)

BOT (ASX) Chart

SPONSORED BY